TPM4 and glioma: In addition, we used WHO grade, chromosome 1p/19q codeletion, primary therapy outcome, IDH status, and TPM4 levels as indicators to construct a prognostic nomogram, which can be employed by physicians to enhance the accuracy of the clinical identification of glioma patients.